SFG
CLGN icon

Strive Financial Group’s CollPlant Biotechnologies CLGN Stock Holding History

Strive Financial Group’s Portfolio CLGN Stock Details CLGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$59 Buy
+169
New +$65 ﹤0.01% 859

Other funds holding CLGN

PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
WPC
Waters Parkerson & Co New Orleans, Louisiana $2.03B AUM 17.65% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.99% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Strive Financial Group's CLGN Position: Q2 2026 in Review

Strive Financial Group opened a new position in CollPlant Biotechnologies (CLGN) in Q2 2026: 169 shares worth $59. The stake represents ﹤0.01% of the portfolio and ranks #859 among its holdings.

6 funds tracked by Wall St. Rank hold CLGN as of Q2 2026.

  • Strive Financial Group held 169 shares of CollPlant Biotechnologies worth $59 as of Q2 2026.
  • CollPlant Biotechnologies was a new Strive Financial Group position in Q2 2026.
  • CollPlant Biotechnologies made up ﹤0.01% of Strive Financial Group's portfolio in Q2 2026, its #859 holding.
  • 6 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q2 2026.

Based on Strive Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.